loading page

Anti-Cancer Drug Delivery Modeling in Nanomedicine with Combinatorial Image Analysis and Non-Linear Regression
  • +2
  • SANJAY GOSWAMI,
  • KSHAMA DHOBALE,
  • RAVINDRA WAVHALE,
  • BARNALI GOSWAMI,
  • SHASHWAT BANERJEE
SANJAY GOSWAMI
Jadavpur University

Corresponding Author:[email protected]

Author Profile
KSHAMA DHOBALE
Maharashtra Institute of Medical Education and Research
Author Profile
RAVINDRA WAVHALE
Maharashtra Institute of Medical Education and Research
Author Profile
BARNALI GOSWAMI
MIT-WPU
Author Profile
SHASHWAT BANERJEE
Maharashtra Institute of Medical Education and Research
Author Profile

Abstract

Purpose: The field of cancer nanomedicine has made significant progress, but its clinical translation is impeded by many challenges, such as the difficulty in analysing intracellular anticancer drug release by the nanocarriers due to the lack of suitable tools. Here, we propose the development of a combinatorial imaging and analysis technique to evaluate anticancer drug such as doxorubicin HCl (DOX) released by a nanocarrier inside the HCT116 colon cancer cells and its subsequent intracellular accumulation. Procedure: Fluorescent cell images were captured and subjected to combined image analysis and machine learning based procedures to assess and quantify the delivery and retention rate of DOX inside the cancer cells by multifunctional CNT-DOX-Fe3O4nanocarrier. Results: We show that DOX in HCT116 cells was higher for multifunctional CNT-DOX-Fe3O4nanocarrierthan free DOX, indicating efficient and steady release of DOX as well as superior retentive property of the nanocarrier. Initially (1 h and 4 h) the luminance intensity of DOX in the cell cytoplasm delivered by CNT-DOX-Fe3O4nanocarrier was ~0.34 times and ~0.42 times lesser than that of free DOX delivered normally. However, at 24 h and 48 h post treatment the luminance intensity of DOX for CNT-DOX-Fe3O4nanocarrier was ~1.98 times and 1.92 times higher than that of free DOX. Furthermore, the luminance intensity of DOX for CNT-DOX-Fe3O4in the whole cell was ~1.35 times and ~1.62 times higher than that of free DOX at 24h and 48 h, respectively. Conclusions: The high-throughput nature of our image analysis workflow allowed us to automate the process of DOX retention analysis, and enabled us to devise machine learning-based modeling to predict the percentage of anticancer drug retention in cells. The development of models to automatically quantify and predict intra-cellular drug release in cancer cells could benefit personalized treatments by optimizing the design of nanocarriers.
30 Dec 2020Submitted to Applied AI Letters
31 Dec 2020Submission Checks Completed
31 Dec 2020Assigned to Editor
06 Jan 2021Reviewer(s) Assigned
24 Apr 2021Review(s) Completed, Editorial Evaluation Pending
28 Apr 2021Editorial Decision: Revise Major
29 May 20211st Revision Received
31 May 2021Submission Checks Completed
31 May 2021Assigned to Editor
02 Jun 2021Reviewer(s) Assigned
12 Jul 2021Review(s) Completed, Editorial Evaluation Pending
13 Jul 2021Editorial Decision: Revise Major
04 Oct 20212nd Revision Received
05 Oct 2021Submission Checks Completed
05 Oct 2021Assigned to Editor
05 Oct 2021Reviewer(s) Assigned
02 Nov 2021Review(s) Completed, Editorial Evaluation Pending
03 Nov 2021Editorial Decision: Accept